Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2011 Mar 24;6(4):626–639. doi: 10.1007/s11481-011-9272-9

Figure 1. Morphine-treated animals exhibit rapid disease progression, retardation in weight gain and higher mortality rates.

Figure 1

(A) Average weight gain over time, in the M and M+V groups, expressed as percent of body weight at week 36 prior to viral inoculation. *p<0.05 vs V group using the Wilcox signed rank test. (B) Survival (expressed as percentage of total animals) of morphine-treated and untreated animals infected with SIV.